Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Krebs

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|February 3, 2005
Crystal-storing histiocytosis in a patient with IgG kappa multiple myelomaEleni Tholouli, Matthew Krebs, Roy Reeve, et al.
Current Treatment Options in Oncology|September 3, 2013
Clinical utility of circulating tumour cell detection in non-small-cell lung cancerAlberto Fusi, Robert Metcalf, Matthew Krebs, et al.
Differentiation; Research in Biological Diversity|September 13, 2003
Actin-filled nuclear invaginations indicate degree of cell de-differentiationNicole Johnson, Matthew Krebs, Rosanne Boudreau, et al.
Asian Journal of Surgery|May 14, 2004
Haemorrhage from pancreatic pseudocysts presenting as upper gastrointestinal haemorrhageGiuseppe Garcea, Matthew Krebs, Tom Lloyd, et al.
BMC Cancer|March 28, 2025
A single centre experience of patients with rare cancers referred for early phase clinical trialsAngelos Angelakas, Natalie Cook, Donna M Graham, et al.
Future Oncology (London, England)|August 27, 2024
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamabAlexander Spira, Nicolas Girard, Matthew Krebs, et al.
Future Oncology (London, England)|August 17, 2023
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamabAlexander Spira, Nicolas Girard, Matthew Krebs, et al.
Cancers|November 28, 2013
Circulating tumor cells, enumeration and beyondJian-Mei Hou, Matthew Krebs, Tim Ward, et al.
BMJ Supportive & Palliative Care|December 1, 2019
Phase I cancer trials: a qualitative study of specialist palliative careSarah Bellhouse, Lucy Galvin, Lorraine Turner, et al.
BMJ Open|October 6, 2021
Oncology patients' experiences in experimental medicine cancer trials: a qualitative studyChelsea Sawyer, Laurie Preston, Sally Taylor, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|February 3, 2005
Crystal-storing histiocytosis in a patient with IgG kappa multiple myelomaEleni Tholouli, Matthew Krebs, Roy Reeve, et al.
Current Treatment Options in Oncology|September 3, 2013
Clinical utility of circulating tumour cell detection in non-small-cell lung cancerAlberto Fusi, Robert Metcalf, Matthew Krebs, et al.
Differentiation; Research in Biological Diversity|September 13, 2003
Actin-filled nuclear invaginations indicate degree of cell de-differentiationNicole Johnson, Matthew Krebs, Rosanne Boudreau, et al.
Asian Journal of Surgery|May 14, 2004
Haemorrhage from pancreatic pseudocysts presenting as upper gastrointestinal haemorrhageGiuseppe Garcea, Matthew Krebs, Tom Lloyd, et al.
BMC Cancer|March 28, 2025
A single centre experience of patients with rare cancers referred for early phase clinical trialsAngelos Angelakas, Natalie Cook, Donna M Graham, et al.
Future Oncology (London, England)|August 27, 2024
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamabAlexander Spira, Nicolas Girard, Matthew Krebs, et al.
Future Oncology (London, England)|August 17, 2023
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamabAlexander Spira, Nicolas Girard, Matthew Krebs, et al.
Cancers|November 28, 2013
Circulating tumor cells, enumeration and beyondJian-Mei Hou, Matthew Krebs, Tim Ward, et al.
BMJ Supportive & Palliative Care|December 1, 2019
Phase I cancer trials: a qualitative study of specialist palliative careSarah Bellhouse, Lucy Galvin, Lorraine Turner, et al.
BMJ Open|October 6, 2021
Oncology patients' experiences in experimental medicine cancer trials: a qualitative studyChelsea Sawyer, Laurie Preston, Sally Taylor, et al.
Pageof 2